cilastatin has been researched along with Chronic Disease in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsumura, N; Oguro, S; Okuno, Y | 1 |
| Matsumoto, T; Otsuka, K; Tomii, K | 1 |
| Amato, G; Bariffi, F; Giacomelli, P; Nani, E; Sanduzzi, A | 1 |
| Casewell, MW; Philpott-Howard, JN; Rolando, N; Wade, JJ; Williams, R | 1 |
| Barberán, J; Borja, J; García-Barbal, J; Gomis, M; Khorrami, S; Sánchez, B | 1 |
| Bentzon, MW; Høiby, N; Jensen, T; Koch, C; Pedersen, SS; Pressler, T; Rosdahl, VT | 1 |
2 trial(s) available for cilastatin and Chronic Disease
| Article | Year |
|---|---|
Transcatheter arterial embolization using imipenem/cilastatin sodium for tendinopathy and enthesopathy refractory to nonsurgical management.
Topics: Adult; Aged; Anti-Bacterial Agents; Arthralgia; Catheterization, Peripheral; Chronic Disease; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Embolization, Therapeutic; Female; Hemostatics; Humans; Imipenem; Male; Middle Aged; Pain Measurement; Protease Inhibitors; Rheumatic Diseases; Tendinopathy; Treatment Outcome | 2013 |
Oral ofloxacin versus parenteral imipenem-cilastatin in the treatment of osteomyelitis.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Chronic Disease; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Humans; Imipenem; Injections, Intravenous; Male; Middle Aged; Ofloxacin; Osteomyelitis; Prospective Studies | 1999 |
4 other study(ies) available for cilastatin and Chronic Disease
| Article | Year |
|---|---|
Mycobacterium fortuitum thoracic empyema: A case report and review of the literature.
Topics: Amikacin; Anti-Bacterial Agents; Chronic Disease; Cilastatin; Cilastatin, Imipenem Drug Combination; Clarithromycin; Drug Combinations; Drug Therapy, Combination; Empyema, Pleural; Humans; Hypercapnia; Imipenem; Male; Middle Aged; Mycobacterium fortuitum; Noninvasive Ventilation; Sulfamethoxazole | 2015 |
Imipenem/cilastatin as monotherapy in the treatment of acute or chronic lung infections: clinical efficacy and safety.
Topics: Acute Disease; Adult; Aged; Bacterial Infections; Chronic Disease; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Humans; Imipenem; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia; Pulmonary Disease, Chronic Obstructive; Safety | 1989 |
The penetration of imipenem/cilastatin into ascitic fluid in patients with chronic liver disease.
Topics: Adult; Anti-Bacterial Agents; Ascitic Fluid; Chronic Disease; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Half-Life; Humans; Imipenem; Liver Diseases; Male; Middle Aged | 1994 |
Combined imipenem/cilastatin and tobramycin therapy of multiresistant Pseudomonas aeruginosa in cystic fibrosis.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bronchopneumonia; Child; Chronic Disease; Cilastatin; Cilastatin, Imipenem Drug Combination; Cyclopropanes; Cystic Fibrosis; Drug Combinations; Drug Synergism; Drug Therapy, Combination; Female; Humans; Imipenem; Kinetics; Male; Microbial Sensitivity Tests; Penicillin Resistance; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Sputum; Thienamycins; Tobramycin | 1987 |